Lexington, MA, United States of America

David B Belanger

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David B Belanger. Retrieved from https://idiyas.com/inventor/david-b-belanger-f6ph1f1t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of David B Belanger

Introduction: David B Belanger, a distinguished inventor hailing from Lexington, MA, has made significant contributions to the field of technology and innovation.

Latest Patents: David B Belanger holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning several decades, David B Belanger has worked with renowned tech companies, leading research institutions, and universities, honing his skills and expertise in innovation.

Collaborations: Throughout his career, David B Belanger has collaborated with top inventors, patent attorneys, and research institutions, fostering a culture of creativity and knowledge sharing in the industry.

Conclusion: David B Belanger's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the technology sector. His contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…